Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 83

1.

History and development of radiation-protective agents.

Weiss JF, Landauer MR.

Int J Radiat Biol. 2009 Jul;85(7):539-73. doi: 10.1080/09553000902985144. Review.

PMID:
19557599
2.

Pharmacologic approaches to protection against radiation-induced lethality and other damage.

Weiss JF.

Environ Health Perspect. 1997 Dec;105 Suppl 6:1473-8. Review.

3.

Protection against ionizing radiation by antioxidant nutrients and phytochemicals.

Weiss JF, Landauer MR.

Toxicology. 2003 Jul 15;189(1-2):1-20. Review.

PMID:
12821279
4.

Protecting people against radiation exposure in the event of a radiological attack. A report of The International Commission on Radiological Protection.

Valentin J; International Commission on Radiological Protection..

Ann ICRP. 2005;35(1):1-110, iii-iv.

PMID:
16164984
5.

Radioprotective effects of amifostine.

Wasserman T.

Semin Oncol. 1999 Apr;26(2 Suppl 7):89-94. Review.

PMID:
10348266
6.
7.

Radioprotection by antioxidants.

Weiss JF, Landauer MR.

Ann N Y Acad Sci. 2000;899:44-60. Review.

PMID:
10863528
8.

New therapy for the prevention and prophylactic treatment of acute radiation syndrome.

Zenk JL.

Expert Opin Investig Drugs. 2007 Jun;16(6):767-70.

PMID:
17501689
9.

Animal models and medical countermeasures development for radiation-induced lung damage: report from an NIAID Workshop.

Williams JP, Jackson IL, Shah JR, Czarniecki CW, Maidment BW, DiCarlo AL.

Radiat Res. 2012 May;177(5):e0025-39.

PMID:
22468702
10.

The potential of amifostine: from cytoprotectant to therapeutic agent.

Santini V, Giles FJ.

Haematologica. 1999 Nov;84(11):1035-42. Review.

11.

Decorporating efficacy of catecholaminocarboxylate chelating agents for thorium-234 and protective effects on associated radiation injury.

Chen H, Luo M, Sun M, Hu Y, Wang Y, Jin M, Cheng W.

Int J Radiat Biol. 2005 Apr;81(4):309-18.

PMID:
16019940
12.

Radioprotectants: current status and new directions.

Grdina DJ, Murley JS, Kataoka Y.

Oncology. 2002;63 Suppl 2:2-10. Review.

PMID:
12466639
13.

Amifostine: the first selective-target and broad-spectrum radioprotector.

Kouvaris JR, Kouloulias VE, Vlahos LJ.

Oncologist. 2007 Jun;12(6):738-47. Review.

14.

Radiation protectants: current status and future prospects.

Seed TM.

Health Phys. 2005 Nov;89(5):531-45.

PMID:
16217197
15.

Radioprotection by polysaccharides alone and in combination with aminothiols.

Patchen ML, MacVittie TJ, Solberg BD, D'Alesandro MM, Brook I.

Adv Space Res. 1992;12(2-3):233-48.

PMID:
11537014
16.

Prevention of radiation-induced central nervous system toxicity: a role for amifostine?

Nieder C, Andratschke NH, Wiedenmann N, Molls M.

Anticancer Res. 2004 Nov-Dec;24(6):3803-9. Review.

17.

Chemical radioprotection: a critical review of amifostine as a cytoprotector in radiotherapy.

Andreassen CN, Grau C, Lindegaard JC.

Semin Radiat Oncol. 2003 Jan;13(1):62-72. Review.

PMID:
12520465
18.

Amifostine in clinical oncology: current use and future applications.

Koukourakis MI.

Anticancer Drugs. 2002 Mar;13(3):181-209. Review.

PMID:
11984063
20.

Protection of normal tissues from radiation and cytotoxic therapy: the development of amifostine.

Castiglione F, Dalla Mola A, Porcile G.

Tumori. 1999 Mar-Apr;85(2):85-91. Review.

PMID:
10363072
Items per page

Supplemental Content

Support Center